Retraction: Nitric Oxide Synthase 2 Induction Promotes Right Ventricular Fibrosis
Overview
Overview
Journal
Am J Respir Cell Mol Biol
Specialties
Cell Biology
Molecular Biology
Molecular Biology
Date
2022 Sep 1
PMID
36047772
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Pulmonary Hypertension and Right Ventricle: A Pathophysiological Insight.
Namazi M, Eftekhar S, Mosaed R, Dini S, Hazrati E Clin Med Insights Cardiol. 2024; 18:11795468241274744.
PMID: 39257563 PMC: 11384539. DOI: 10.1177/11795468241274744.
References
1.
Budas G, Boehm M, Kojonazarov B, Viswanathan G, Tian X, Veeroju S
. ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2017; 197(3):373-385.
DOI: 10.1164/rccm.201703-0502OC.
View
2.
Boehm M, Arnold N, Braithwaite A, Pickworth J, Lu C, Novoyatleva T
. Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension. BMC Pulm Med. 2018; 18(1):41.
PMC: 5833097.
DOI: 10.1186/s12890-018-0604-x.
View
3.
Boehm M, Novoyatleva T, Kojonazarov B, Veit F, Weissmann N, Ghofrani H
. Nitric Oxide Synthase 2 Induction Promotes Right Ventricular Fibrosis. Am J Respir Cell Mol Biol. 2018; 60(3):346-356.
DOI: 10.1165/rcmb.2018-0069OC.
View